1072902-75-0 Usage
Description
N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester is a complex organic compound with a unique molecular structure. It is derived from L-isoleucine, an essential amino acid, and is characterized by its specific stereochemistry and functional groups. This molecule has potential applications in various fields due to its structural properties and interactions with other molecules.
Uses
Used in Pharmaceutical Industry:
N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester is used as a pharmaceutical compound for its potential therapeutic effects. The molecule's unique structure allows it to interact with specific biological targets, making it a candidate for the development of new drugs.
Used in Research and Development:
In the field of research and development, N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester serves as a valuable tool for studying the interactions between molecules and their biological targets. Its unique properties can help researchers understand the mechanisms of various diseases and develop targeted therapies.
Used in Drug Design:
N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester is used in drug design as a starting point for the development of new pharmaceuticals. Its structural features can be modified to create more potent and selective compounds with improved pharmacological properties.
Used in Chemical Synthesis:
In the chemical synthesis industry, N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester can be used as a building block for the synthesis of more complex molecules. Its unique functional groups and stereochemistry make it a versatile component in the creation of novel compounds with various applications.
Used in Cosmetics Industry:
N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester may also find applications in the cosmetics industry, where it could be used as an active ingredient in skincare products. Its potential to interact with biological targets may provide benefits for skin health and appearance.
Check Digit Verification of cas no
The CAS Registry Mumber 1072902-75-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,2,9,0 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1072902-75:
(9*1)+(8*0)+(7*7)+(6*2)+(5*9)+(4*0)+(3*2)+(2*7)+(1*5)=140
140 % 10 = 0
So 1072902-75-0 is a valid CAS Registry Number.
1072902-75-0Relevant articles and documents
NOVEL LIPASE INHIBITORS, REPORTER SUBSTRATES AND USES THEREOF
-
Paragraph 0137, (2014/01/07)
The invention provides for novel lipase inhibitors, and compositions and devices comprising the same. The invention further provides for methods for treatment o f disorders comprising administration o f novel diacylglycerol lipase inhibitors, and com -positions and devices comprising said inhibitors. In some embodiments, the disorders are pancreatitis, obesity, shock or pancreatic necrosis. The invention further provides for novel ether lipid reporter compounds and methods o f assaying enzymatic activity com -prising contacting a compound with a novel ether lipid reporter compound.
Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism
Ortar, Giorgio,Bisogno, Tiziana,Ligresti, Alessia,Morera, Enrico,Nalli, Marianna,Di Marzo, Vincenzo
experimental part, p. 6970 - 6979 (2009/11/30)
A series of 21 analogues of tetrahydrolipstatin (THL, 1) were synthesized and tested as inhibitors of the formation or hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG). Three of the novel compounds, i.e., 11, 13, and 15, inhibited 2-AG formation via the diacylglycerol lipase α (DAGLα) with IC50 values lower than 50 nM (IC50 of THL = 1 μM) and were between 23- and 375-fold selective vs 2-AG hydrolysis by monoacylglycerol lipase (MAGL) as well as vs cannabinoid CB1 and CB2 receptors and anandamide hydrolysis by fatty acid amide hydrolase (FAAH). Three other THL analogues, i.e., 14, 16, and 18, were slightly more potent than THL against DAGLα and appreciably selective vs MAGL, CB receptors, and FAAH (15-26-fold). One compound, i.e., 8, was a potent inhibitor of MAGL-like activity (IC50 = 0.41 μM), and relatively (～7-fold) selective vs the other targets tested.
